Abstract:The inhibitory effects against human protein tyrosine phosphatase 1B (PTP1B), T-cell protein tyrosine phosphatase (TCPTP), megakaryocyte protein tyrosine phosphatase 2 (PTP-MEG2), srchomology phosphatase 1 (SHP-1) and srchomology phosphatase 2 (SHP-2) of five zinc(I) complexes with multi-benzimidazole derivatives, [Zn(TDB)(2)]Cl-2 (1), [Zn(NTB)Cl]Cl (2), [Zn(EDTB)]Cl-2 (3), [Zn-2(EGTB)Cl-2]Cl-2 (4) and [Zn-2(DTPB)Cl-3]Cl (5) (TDB=1,2-bis(1H-benzo-imidazol-2-yl)ethane-1,2-diol, NTB=tris(1H-benzoimidazol-2-ylmethyl)amine, EDTB=N,N,N',N'-tetrakis (1H-benzoimidazol-2-ylmethyl)ethane-1,2-diamine, EGTB=bis(1H-benzoimidazol-2-ylmethyl)-[2-(2-{2-[bis-(1H-benzoimidazol-2-ylmethyl)-amino]ethoxy}ethoxy)ethyl]amine and DTPB=1,1,4,7,7-pentakis (1H-benz-imidazol-2-ylmethyl)-1,4,7-triazaheptane), were evaluated in vitro in this paper. The five zinc(II) complexes potently inhibit PTP1B with IC50 at range from 0.15 to 0.28 mu mol . L-1,but show weaker inhibition against PTP-MEG2, SHP-1, almost no inhibition against SHP-2. It is interesting that complexes 2 and 4 exhibit weaker inhibition than 1, 3 and 5 against TCPTP that is highly homologous with PTP1B. Therefore, 2 and 4 display obvious selective against PTP1B with 7 similar to 12 times stonger than against TCPTP, 10 similar to 15 times stonger than against PTP-MEG2, 20 similar to 40 times stonger than against SHP-1 and about 1 000 times stonger than against SHP-2, suggesting the structure of zinc(II) complexes influence the selectivity against PTP1B. Kinetic analysis indicates that complexes 2 and 4 are reversible competitive inhibitors of PTP1B but noncompettitive inhibitors for TCPTP. Fluorescence study on the interaction between complex 2 or 4 and PTP1B or TCPTP suggests that the complexes bind to PTP1B or TCPTP with the formation of a 1:1 complex. The binding constant are about 1.12x10(6), 5.47x10(5), 1.19x10(6), and 4.95x10(5) L.mol(-1) respectively, showing stronger binding ability of 2 and 4 to PTP1B than to TCPTP, agreeing with their inhibition against the two enzymes.

Protein tyrosine phosphatase inhibition by metals and metal complexes.

Metal-Based Inhibitors of Protein Tyrosine Phosphatases

Exploration of Zinc(II) Complexes As Potent Inhibitors Against Protein Tyrosine Phosphatase 1B

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

Targeting PTPs with small molecule inhibitors in cancer treatment

Recent Advances in the Development of Allosteric Protein Tyrosine Phosphatase Inhibitors for Drug Discovery.

Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases

Recent Advance on PTP1B Inhibitors and Their Biomedical Applications.

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation

Advance in regulatory mechanism research of protein tyrosine phosphatases

Structure-Based Discovery of Small Molecule Inhibitors Targeted to Protein Tyrosine Phosphatase 1B

Ptps Inhibition by Zinc(Ii) Complexes with Multi-Benzimidazole Derivatives

Druggable targets of protein tyrosine phosphatase Family, viz. PTP1B, SHP2, Cdc25, and LMW-PTP: Current scenario on medicinal Attributes, and SAR insights

Potent Inhibition of Protein Tyrosine Phosphatase 1B by Copper Complexes: Implications for Copper Toxicity in Biological Systems

Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics

Protein tyrosine phosphatase 1B in metabolic diseases and drug development

Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors

Crystal Structure of PTP1B Complexed with a Potent and Selective Bidentate Inhibitor

Cellular Inhibition of Protein Tyrosine Phosphatase 1b by Uncharged Thioxothiazolidinone Derivatives

Heavy Metal-Induced Metallothionein Expression is Regulated by Specific Protein Phosphatase 2a Complexes

Investigation of Selective Binding of Inhibitors to PTP1B and TCPTP by Accelerated Molecular Dynamics Simulations.